Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Mar 08, 2024 10:42am
63 Views
Post# 35922667

RE:RE:Why is AEZS trading below the cash value?

RE:RE:Why is AEZS trading below the cash value?
lscfa wrote: "Why does it take so long to find a new partner for the US market?" AEZS wants to do a single license of Macimorelin for adult and child use so waiting for child clinical results. 



That's crazy. Why doesn't AEZS market the test to children without childhood clinical trial data? Are you sure they are even running a trial for children? How do you even know? Why do children need growth horomone anyways? If the management team was competent they would find a way to do it without a trial. Clearly fossi is onto something. fossi knows more than Ronnie Miller and the Board of Directors combined; especially Gilles who is on the Board of Directors of AEZS as a diagnostic deal is being negotiated. It's all in the stock chart. The diagnostic test is a big, fat ZERO.
<< Previous
Bullboard Posts
Next >>